Biotin-induced thyroid stimulating hormone aberrations in the setting of immunotherapy.
Forrest N RidgwayKathryn A GoldLinda C BarnacheaPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
The purpose of this report is to provide the first known incidence of biotin complicating the routine monitoring of immune checkpoint inhibitors with elevated TSH levels and to alert providers to elicit accurate medication histories regarding over-the-counter supplements.